Delivery Order HHSN261201600018I-75N91019F00090

The National Cancer Institute issued a delivery order to Southern Research Institute on December 18, 2018, under the Toxicology of Drugs Developed for Cancer Patients IDIQ, with a ceiling value of $358,997.

The order funds a toxicology study of human complement factor H antibody GT103 in mice. Place of performance is Birmingham, AL. Period of performance runs from December 19, 2018, through March 31, 2020. The contract is priced on a cost-plus-fixed-fee basis with no set-aside.

Southern Research self-performed the work; no subcontractors were reported. In fiscal year 2020, the order generated $154 thousand in invoiced labor, with all hours performed by the prime.